Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Sanofi's Infilbray wins first approval for neurological symptoms of Gaucher

Sanofi won approval Wednesday for Infilbray, the first drug in the US to treat the neurological symptoms of a rare genetic disorder called Gaucher disease. Infilbray, also known as venglustat, crosses the blood-brain barrier to ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Every outlet that reported this, and when →

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 19 November →